Opportunities to engage with STAT reporters and leading industry experts
Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma and health tech leaders. See what we have scheduled for this month, and register below — and, if you missed them, be sure to view past conversations in our archive.
NOV 24
Your unanswered questions from the STAT Summit
Our STAT Summits always produce more questions than we can answer during the event. As a special for our STAT+ subscribers, we’ll be answering some of those that were left unanswered, and taking new questions about what the rest of the year has in store for biopharma.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
